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Polychlorinated biphenyls (PCBs) are ubiquitous global contaminants that have been intensively
investigated for three decades. They are broad-acting toxicants occurring in complex mixtures
and accurate risk assessment has proven to be elusive. Focusing on a limited set of end points
and emphasizing a fixed set of congeners have led to more streamlined data sets that are meant
to expedite hazard characterization and risk assessment for the most potent congeners-aryl
hydrocarbon receptor (AhR) agonists. Unfortunately, this has made it impossible to confirm or
deny significant contributions from the more prevalent components of the mixtures. PCBs may
be only coincidentally present, rather than causal, in some diseases. Still, attempts to determine
associations with incomplete residue data may lead to erroneous conclusions and make accurate
risk assessment even more elusive. Responses not mediated through the AhR are presented and
emphasize large data gaps. Dissimilar analytical reports emphasize that selection of analytes is
not consistent. Collectively, these data confirm that AhR-focused objectives unintentionally
created the impression that nonplanar PCBs have little if any potential for hazards to humans and
wildlife. Near steady-state exposure of healthy adults are probably of minor consequence except
for emerging correlations with non-Hodgkin's lymphoma; however, pulses of exposure to more
labile mixtures may contribute to developmental effects without leaving a residue record. More
broadly based criteria are suggested and harmonization of data collection and presentation are
desirable. A more comprehensive list of PCB congeners is proposed that would provide more
adequate data upon which to base associations with adverse outcomes. - Environ Health
Perspect 106(Suppl 1):171-189 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-1/1171-
189hansen/abstract.html
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The recently proposed reclassification of
individual polychlorinated biphenyl (PCB)
congeners (1) is welcome, but is only a step
in the right direction. The rationale was "to
organize risk analysis along biologically
plausible lines, thereby avoiding misclassifi-
cation of exposure and strengthening the
toxicologic associations" (1). The possible
toxicologic associations must be more com-
prehensive. The next step toward enhanc-
ing the accuracy ofrisk analysis is to base
the associations on more accurate concepts
ofexposure.
Because PCBs are found in nearly every
organism and matrix examined, some ofthe
associations with diseases may well be coin-
cidental. These associations may also
merely reflect physiological changes due to
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the disease that enhance accumulation of
lipophilic chemicals. Even ifPCBs do not
prove to be guilty ofall the adverse effects
forwhich they are suspected, it is important
to determine the real hazards. The tremen-
dous database generated can also serve as a
guide for evaluating similar mixtures such
as toxaphene, other pesticide mixes, petro-
leum hydrocarbons, diesel emissions,
polynuclear aromatic hydrocarbons, and
water disinfection byproducts. The data-
base also permits examination of basic
physiological, biochemical, and molecular
mechanisms with well-defined structural
probes. This review does not claim to
include all aspects of PCB toxicity and
occurrence. Rather it presents select tox-
icities supported by specific information
and suggests other criteria for consideration
in compiling a more complete list of
congeners ofconcern. The proposed list of
congeners is also based on more compre-
hensive occurrence and exposure data than
in previous lists.
Ifexposure data are incomplete, impor-
tant associations may be overlooked or
misassigned. Earlier PCB priority classifica-
tion criteria and schemes (2-5) were pre-
mature (6-8) and overfocused on the
single set of aryl hydrocarbon receptor
(AhR)-mediated end points (8-10). In
spite of suggestions to consider other
toxicities (7-11), the limited breadth still
dominates. Analytical limitations and com-
plexities also favored selective screening
(3,5). In fact, the complete characteriza-
tion of some PCB mixtures released into
the environment has only recently been
accomplished (12).
The most important development for
assessment of potential hazards and risks
associated with the 209 possible chloro-
biphenyl (CB) congeners and various mix-
tures has been the mechanistic linkage of
certain configurations with 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD)-like
activity via the AhR (7,13 ). Much of the
work was based on the observation that
PCBs induced both phenobarbital (PB)
and 3-methylcholanthrene (3-MC) types
ofcytochrome P450 activities.
It was readily shown that non-ortho and
mono-ortho CBs with lateral chlorines were
highly potent and equivalency to TCDD
could be predicted based on enzyme induc-
tion and other parameters (2-4>7,10,11,13).
The toxic equivalency (TEQ) of a mixture
could be determined by summing the prod-
ucts ofeach component times its equivalence
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to TCDD (7). TCDD equivalent is more
accurate, as compounds with no equivalency
to TCDD can still be toxic by other mecha-
nisms. In spite oftheir relatively low envi-
ronmental levels (9,12,14) the coplanar and
potentially coplanar PCBs frequently con-
tributed more TCDD equivalents than all
dioxins, induding TCDD (15-17); on the
other hand, polychlorinated dibenzofurans
(PCDFs) may contribute significantly
greater TCDD equivalents than PCBs
and/or polychlorinated dibenzo-p-dioxins
(PCDDs), depending on the environmental
source ofthe mixture (17,18). It was not
the apparent intent ofthese efforts to deter-
mine TCDD equivalencies to exclude all
other toxicities; however, the momentum
provided for compiling more restricted lists
ofanalytes to be reported has made it more
difficult to detect ordenyother associations.
Selection Criteria
Given the high potencies and low levels of
coplanar CBs, analytical priorities became
necessary for routine screening oflarge
numbers ofsamples (3,19,20). In addition,
large data sets that might include extrane-
ous or less important congener values are
difficult to interpret. Therefore, selective
lists were developed based on "toxic poten-
tial and occurrence" (5,19-21) or other
factors such as occurrence and metabolic
clearance (22).
Regulatory decisions and analytical
considerations drove some lists (20), but
toxicological considerations were based
mostly on AhR potencies. Only about a
dozen CBs exhibit significant AhR poten-
cies (7,11,13). The small proportion ofthe
209 congeners considered can be seen by
comparing the proposed lists with the list
of congeners generally accepted as being
dominant in commercial preparations (12)
(Table 1). Additional congeners oflittle
environmental relevance are included for
later consideration in structure-activity
relationships (SARs).
The improved analytical capabilities and
detailed characterizations of commercial
mixtures (12,19) are complemented by a
better understanding of the systematic
changes in molecular properties ofthe indi-
vidual CBs. These properties have been
summarized in a single source (23) and this
has facilitated modeling ofenvironmental
dispersion, toxicokinetics, and receptor
interactions. Thus, we are now in a more
favorable position to resolve many ofthe
ambiguities in the risk assessment ofPCBs.
Even though a major concern ofthis artide
is stepping back to gain a more complete
view ofthe PCB congeners present, some
toxicological justifications for expanding
the profile ofcongeners reported will be
presented first.
Toxicities Independent
ofthe Ah Receptor
PCBs are very broad-acting toxicants (7-9)
and AhR-mediated responses represent a
limited spectrum oftoxicities. More subtle
and, perhaps, more insidious responses to
the remaining 190 congeners are poorly
defined. More than halfofthese, including
some very prevalent CBs, have not even
been investigated. Other than enzyme
induction, the largest database (about 35
CBs) was generated by Shain and col-
leagues for dopamine depletion (24).
Kodavanti and colleagues determined the
stimulation ofphorbol ester binding (25)
and inhibition of calcium sequestration
(26) in the cerebellum for 24 congeners,
most ofwhich overlapped those ofSeegal.
Shorter lists have been investigated for acti-
vation of microsomal ryanodine-sensitive
calcium channels (27), activation of neu-
trophils (28,29), and stimulation ofinsulin
release (30). In all of these assays, the
major theme has been that lower chlori-
nated and ortho-chlorinated congeners are
the most potent, and coplanar congeners
have essentially no activity. Derived rela-
tive potencies ofvarious congeners toward
neurochemical end points are presented in
Table 2.
Responses Mediated by
Multiple Mechanisms
DisrupdonofThyroid
HormoneHomeostasis
Nearly all CBs and PCB mixtures disrupt
thyroid hormone homeostasis by a variety
ofmechanisms or combinations ofmecha-
nisms (17,31-43). However, most thyroid
studies have focused on higher chlorinated
and higher TCDD TEQ congeners and
similar mixtures such as Aroclor 1254.
Data are scant for lower chlorinated Aro-
clors and the 40 to 80 more common con-
geners that might contribute to the thyroid
effects. Coplanar AhR agonists are usually
more potent, but removal of these com-
pounds from complex mixtures does not
always attenuate thyroid effects (37). One
of the earliest demonstrated mechanisms
for declines in serum thyroxine (T4)
involved enhanced excretion following
induction of T4 conjugation through
UDP-glucuronosyltransferases (UDPGTs)
(31,32). This has been proposed as the
major mode ofTCDD disruption ofthy-
roid hormone homeostasis (36); neverthe-
less, environmental PCB mixtures with
distinctly different TCDD TEQs had simi-
lar potencies for T4 depletion (17) and
removal ofAhR agonists from a mixture of
primarily tri- and tetra-CBs did not affect
acute T4depletion (37).
Other than binding ofhydroxy-PCBs to
prealbumin (transthyretin), there are limited
data to derive SARs for PCB effects on thy-
roid hormones because most studies were
conducted with Aroclors. Effects ofspecific
congeners have been reported in isolated
studies with major differences in age, gen-
der, and dosing protocols; however, some
insight into PCB mechanisms ofthyroid
hormone disruption can be gained by dis-
cussing reported effects for PCB mixtures
and individual CBs.
After acute (2-day) exposures, thyroid-
stimulating hormone (TSH) levels may
increase up to 5-fold (38) and the thyroid
follicles show typical responses (32,39) to
TSH-stimulated mobilization of T4
(39-41). The follicular response (increased
cell height and decreased colloid area)
appears maximal at doses below those at
which significant declines in serum T4 are
seen (40,41). Mobilization of stored T4
from the thyroid follicles at doses lower
than or times prior to those causing signifi-
cant UDPGT induction (17,38) can cause
elevations in serum T4 (17,42,43); at
higher doses, declines in serum T4 are still
seen at times prior to maximal UDPGT
induction (17,38,42,43).
Modestly chlorinated congeners such as
CB 47 and mixtures such as Aroclor 1242,
as well as labile 2,3,6-substituted CBs, can
acutely decrease serum T4 to a greater
extent (17,37,38,40,42,43) than more
highly chlorinated congeners such as CBs
99 and 153 (43,44). Thus, mechanisms
other than UDPGT induction, including
direct effects on the thyroid gland (32,33),
are also important and this makes additive
and/or synergistic effects likely. Also, a
strict TEQ approach will underestimate
the thyroid hormone disruption potential
of some environmental mixtures (17) as
well as these congeners.
Long-term responses to Aroclor 1254
indude direct thyroid effects (32,33) as well
as pathological changes in liver, kidneys, and
gastrointestinal tract (7-9). Collectively,
these changes may be related to changes in
the distribution ofthyroid hormones, result-
ing in decreased serum levels that cannot be
attributed to enhanced metabolism and
clearance (33). TSH release from the
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Table 1. Structures ofchiorobipheyl congeners referred to inthe textand inclusion in selective listsofcongeners of importance. Designationsofgrouportype in schemesB
andCareaspublishedandthesamecriteria mayusedifferentcodes.
B&Z
no.'
Chlorine .Scheme Scheme Scheme Europe B&Z
RingA RingB PS .d DBC no.'
Chlorine Scheme Scheme SScheme Europe
RingA RingB Ab 'B Cd DO
82 234 23 +
85 234 24 +
88 2346 2 -_
92 235 25
100 245 23
103 246 2
105. 234 34 ++ .1B 2A [+]
114 2345 4 4
119 -246_3
126 345 34 ++ IA 2A
132 234 236
136 236 236
-- ----- .. litt. ~ ~~~~ ~ ~ ~ ~~~~~~~~~
.157 234 344
1634 2356 34
169 345 345: 1A 2A
171 2346 234
177 2356 234 3 lB
180 234 245 2 3
182: 2345 246 -
187 24563245
.190 23456 34
196 234.5 2346 + 3
203 23456 245 + 3
8t '345 4 - 4 209 23456 23456
'Numbering according to Ballschmiter and Zell (14) as revised (12,19)..CB 199(revsed nomenciature) was referred to as Ce 201 in theorginal designationsand,thus, in
earlier residue reports. *GM Frame, personal communication. lmpodant congeners are indicated by(+) or, especially important, in) based oncoplarity, ocurence in
Aroclors, dechlorination products, andanalytical considerations. Congeners safely ignored are indicated byH-). °Critera forgroups: 1A,the'three pureMC-typeinducers; 1B,
the more potent and relatively abundantofitemixed inducers; 2, abundant known orpredicted PB-type inducers; 3, abundantweakinducerswhich occurfrequently in fish
and invertebrates;4, mixed inducers-of lowoccurrence(5).dCritriaforgroups: High occurrence in housedustand humansand/ordemonstratedbiologicalactivity. A. weak
PB inducers, estrogenic, not persistent t1B,weak PO inducers,persistent 2A, dioxinlike, moderatelypersistent 2B, limited dioxinlike,.persistent; 3. PB and 3-MC inducers,
persistent(1). 'Theseven majorcongeners regulated,++; Finland includesCBs 8and 18,(+); QualityAssuranceof Information for Marine EnvironmentalMonitoring inEurope
(QUASIMEME)additional congeners, 1+](190).
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2
3 -4
5 .23
1.1 3 3
15 4 4 ++
17 .24 2 ++.
RU NE .........1 1.
19 ..26 2
22 23 4. +
25 24 3'
28 24 4
31 25 4 1.A
33 34
39 35 4
41 234' 2
44 23 25 3 1A
46 .23 26
48 245 2
50 .2
52 .25.
++
gn
54 26 26
234....
64 236 4'.'
69 248
71 26 34.
75 246 .4
77 34 34
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Table 2. Relative potencies of chlorobiphenyls in four different neurotoxicity bioassays. The 15 most abundant
congeners and the reference potencyforthe mostactive congeners are indicated by bold numerals.
B &Z no. Dopamine depletiona Phorbol bindingb Brain calciumc Brain calcium channelsd
MonoCI
1 0.35
2 0.21
3 0.19
DiCI
4 1.00 0.65 0.30 0.50
11 0.33 0.47 0.19
14 0.29 0.38 0.14
15 0.00 0.00
TriCI
18 0.78
19 0.48 0.34
21 0.32
24 0.40
25 0.28
26 0.40
28 0.33 <0.3 0.35
30 0.43
31 0.36
33 0.35
39 0.21
TetraCI
40 0.11
44 0.56
47 0.56 0.31 0.41
49 0.66
50 0.90 0.68 0.33
51 0.56 1.00
52 0.74 1.00 0.49 0.33
54 0.00 0.00 0.00 0.00
66 0.25 0.00
69 0.82
70 0.10
75 0.54
77 0.00 0.00 0.00
80 <0.03
PentaCI
88 0.19
95 1.00
100 0.41
103 0.41 0.34
104 0.69 0.74 0.44 0.11
105 0.29 0.45
118 <0.3 0.36
126 0.00 0.00 <0.03 0.00
HexaCI
128 <0.3 0.49
133 <0.3 0.47
136 0.48 0.38
153 <0.3 0.36 0.10
155 0.41
156 <0.3 0.44
169 0.00 0.00
HeptaCI
171 0.48
180 0.00 0.50
181 0.17
183
aPheochromocytoma cells[(24); R Seegal, personal communication]. bincreased phorbol ester binding in cerebellar
granule cells (25). clnhibition of calcium uptake by cerebellar microsomes (26). dActivation of ryanodine binding to
cerebellar microsomes [(27);1 Pessah, personal communication].
pituitary does not appear to be impaired by
Arodor 1254 or Firemaster BP-6 (33). Yet,
in contrast to Aroclor 1242 (38,43), TSH
increases are very modest in response to
Aroclor 1254 (33,34) and the thyroid
response to TSH is decreased by Aroclor
1254 (32,33), further supporting mecha-
nisms in addition to increased clearance.
One mechanism related to clearance is
displacement of T4 from prealbumin
(transthyretin) by hydroxylated PCBs,
PCDFs, and PCDDs; however, these com-
pounds do not displace T4 from thyroxine-
binding globulin, which is a more
important transport protein in humans
than is prealbumin (32,34,35). Earlier
work from Brouwer's group had shown
that hydroxy-PCBs had profound effects
on rat serum T4 as well as retinol because
the prealbumin-displaced T4 was more
readily metabolized by induced enzymes
and more rapidly excreted. Prealbumin is
thought to be important in translocation of
T4 into the brain so this mechanism may
be related to neurotoxic effects of PCBs;
however, the competitive binding effect on
serum T4 is probably much less important
in man than in rodents (35).
Although enhanced clearance ofT4
through AhR-mediated induction of
UDPGTs may be the major mechanism
for thyroid disruption by TCDD, addi-
tional mechanisms are obviously involved
in thyroid disruption by the more broadly
acting PCBs. Some direct effects on the
thyroid gland include:
* Decreased iodine uptake and/or T4
synthesis (32)
* Decreased mobilization (higher chlori-
nated) (32)
* Enhanced mobilization (lower chlori-
nated) (40-43); this is a classic TSH
response (32), but still may not be
TSH-mediated in these cases
* Inhibition ofresponse to TSH (33)
The different responses to lower chlori-
nated congeners and Aroclor 1242 as com-
pared to Aroclor 1254 may be related to
the weak estrogenicity of these lower
chlorinated PCBs (44-48), which may also
be proestrogens (49). The more slowly
metabolized Aroclor 1254 may yield
metabolites that tend to be antiestrogens
(50) and the parent mixture contains a
greater proportion ofantiestrogenic CBs
than does Aroclor 1242 (12,51,52).
Similar to estradiol, Aroclor 1242 sensitizes
pituitary cells to gonadotropin-releasing
hormone within a narrow dose range (51).
Estradiol causes a similar sensitization at
the thyrotrope level (32), so modest accu-
mulation of estrogenic PCBs would
enhance TSH release. It would be antici-
pated that greater accumulations (longer
exposure and, especially, higher chlorinated
and antiestrogenic Aroclor 1254) would
inhibit release.
There are also effects on catabolism,
transport, and storage ofthyroid hormones
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in addition to those related to UDPGT
induction. De-iodinases can be increased
and decreased by Aroclor 1254, depending
on age and gender (34) and sulfatase con-
jugation of T3 might also be increased
(32). Binding to transport proteins is
affected by PCB metabolites (35). The
liver contains a greater reserve of extra-
thyroidal T4 than does the serum (32), and
hepatic enlargement by PCBs is well
documented (7,9,11,33); thus, the effects
of Aroclor 1254 and polychlorinated
biphenyls on T4 distribution may signifi-
cantly influence serum levels of thyroid
hormones without changing whole-body
reserves (32,33).
All of these mechanisms have potential
for interactive effects, so the effect ofPCBs
on thyroid hormones is probably much
more complex than that of TCDD.
Additional SARs for acute effects of low-
dose CBs on thyroid hormones are needed
before any consistent patterns can be eluci-
dated. A more direct comparison of
Aroclors 1242 and 1254 would also con-
firm or deny ifthyroid responses were dif-
ferent or ifthe different responses reflected
different experimental designs.
The consequences of transient hypo-
thyroidism in healthy adults are probably
not severe, so contributions from PCBs
should be ofminimal public health signifi-
cance. Nevertheless, immature animals,
includinghumans, are differentially sensitive
to thyroid hormone disruption during criti-
cal windows of development. Therefore,
exposure to pulses oflabile CBs may result
in manifestations ofhypothyroidism (or
even briefhyperthyroidism) not apparent
until evidence of exposure (residues) no
longer exists. Potential for these pulses will
be discussed later, but the relevance to bio-
logically plausible toxicologic associations is
immediately obvious.
Estrogenic andAntiestrogenicEffecu
PCBs have long been known to be estro-
genic (45-48), but in vitro estrogen recep-
tor (ER) binding is not strong (48) except
for some lower chlorinated hydroxy
metabolites (HO-CBs) (49). More persis-
tent higher chlorinated HO-CBs have been
reported to be antiestrogenic (50).
Coplanar AhR agonists are also generally
considered to be antiestrogenic (51,52), but
coplanar CB 77 may act as an estrogen in
some assays (53) and coplanar CB 126 is
uterotropic atvery low doses (42,54).
Uterotropic activity in immature female
or ovariectomized adult female rodents has
been the accepted standard of estrogenic
activity, but it can be a relatively insensitive
end point (55-57). Other reproductive
tract changes and enhanced gene expres-
sions can be used ifthe uterotropic effect is
ambiguous (55,56), but these end points
are not predictive ofER-dependent respon-
ses in other tissues (57). Likewise, in vitro
ER-binding studies may not accurately pre-
dict relative in vivo estrogenic actions for
different agents (38,50,56,57).
Thus, the many attempts to confirm or
deny the significance of estrogenic and
antiestrogenic actions of PCBs have failed
to reach a consensus. Because ofthe mag-
nitude of the impact of globally distri-
buted persistent xenoestrogens, it is
important to accurately determine the
potential hazards. It is unlikely that the
data generated to date is adequately reliable
for accurate hazard assessment because of
the many and variable actions of PCBs
interacting with the many and variable
responses of estrogen-sensitive targets.
Some considerations include:
* Wide-ranging and systematic differ-
ences in the molecular properties of
individual PCBs (23), including recep-
tor-binding potencies (58,59)
* Presence of at least two distinct ERs
with significant differences in the lig-
and-binding domain, resulting in dif-
ferent affinities for xenoestrogens (60)
* Cell-specific modulation ofresponses of
even the same ER to different ligands
(57,61-64), mainly because ofreceptor-
associated proteins required for tran-
scriptional activitybythe entire complex
* Point 3 is compounded by extremely
limited data on PCB interactions with
ERs other than from uterus or breast
tissue
* Attempts to assess relative potencies
from tests conducted under nonphysio-
logical conditions (e.g. protein binding,
endogenous hormone levels, other hor-
mone modulators, in vitrocytotoxicity)
* Reluctance to recognize nonmonotonic
dose-response relationships in spite of
the effects ofPCBs on all ofthe interac-
tive factors listed above, as well as on
enzyme levels and toxicokinetics.
To assess relevant ER-associated hazards
ofPCBs, it is more important to determine a
number ofdifferent tissue-specific responses
in live animals rather than multiple responses
in the same tissue or in similar in vitro sys-
tems (38,56-58,61,64). The reported estro-
genic/antiestrogenic activities of PCBs are
highly variable and response specific because
of the natures of the assays employed.
Perhaps some harmonization ofthe assays
would be helpful in this assessment. In the
meantime, it is necessary to attempt to nor-
malize the data (as in Table 2) to permit
some direct comparisons.
Table 3 compares recent demonstrations
of in vitro ER binding and in vivo
uterotropic activities for specific CB con-
geners. The attempt to normalize in vitro
data to relative potencies was much less
straightforward for Table 3 than for Table
2 and these values should not be directly
compared except within the same study.
Some unpublished data from our laborato-
ries are included to increase the proportion
ofenvironmentally relevant congeners.
Uterotropic responses are also notstrictly
comparable because experimental designs
differed. Ranges ofdoses for some CBs,
induding some that failed to cause a signifi-
cant response, are presented to demonstrate
that nonmonotonic responses may be com-
mon (42,44,53,71,74). For perspective,
uterotropic response to the known xeno-
estrogen, o,p-DDT, was induded under con-
ditions similar to many ofthe other studies
(17,37,42,44,66-69,71).
A few estrogenic lower chlorinated
HO-CBs are also included for comparison.
Mainly antiestrogenic activities have been
reported for higher chlorinated HO-CBs
(50,75), persistent in human blood and
various environmental sources (76). How-
ever, these data were even more difficult to
extract and normalize, except for relative
binding to ER from human MCF-7 cells
(75). In addition, some ofthe antiestro-
genic activities were attributed to cytotox-
icity (75) and the type ofresponse varied
with the added concentrations ofestradiol
(75). Finally, the very properties that favor
retention ofthese metabolites in the blood
would render them less available to tissues
(77). Indeed, the more highly chlorinated
mixtures (from which these metabolites
arise) have weaker in vivo estrogenic poten-
tial than the lower chlorinated mixtures
(45-48,75). Therefore, these data are not
presented, but the distinction between
lower chlorinated HO-CBs and persistent
HO-CBs should be considered.
Table 3 demonstrates poor resolution
among congeners when only estrogenic
potency in MCF-7 cells is considered, and
rather poor in vivopredictabilityofERbind-
ing in some cases. Tight protein binding
(e.g., to prealbumin) is considered to be
partly responsible for retention ofpersistent
HO-CBs in the blood (35,76) and endoge-
nous estrogen is also mostly bound to other
proteins in serum; in vitro assays that take
this serum protein binding into accounthave
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greater predictability for in vivo responses to
weak estrogens (77). Because ofthe pro-
found effects ofPCBs (7,17,38) as well as
dosage vehicles (72,73) on biotransforma-
tion enzymes and the enhanced activities of
some primary metabolites (49), toxicoki-
netic changes can readily influence the out-
come ofin vivo tests. In addition to protein
binding considerations and dichotomous
effects on ER-modulatingthyroidhormones,
these enzyme changes may also account for
some ofthe nonlinearity in dose-response
relationships (38,44,67,74,77).
Although the uterotropic response is
relatively insensitive, a significant effect at
modest doses confirms at least the potential
for weak estrogenic activity. Male (74,78)
as well as female reproductive tissues and
other tissues such as bone (61) and pitu-
itary (51,57,79-81) are also sensitive to
environmental estrogens as well as endoge-
nous estradiol. In fact, the pituitary ryan-
odine receptor appears to be involved in
GnRH-induced gonadotropin synthesis
and secretion (81). Ryanodine-sensitive
calcium channels are stimulated by di- and
tri-ortho CBs (27) (Table 2); the weakly
estrogenic Aroclor 1242 (44-46,51,67)
also stimulates ryanodine-sensitive chan-
nels (I Pessah, personal communication)
and enhances pituitary GnRH-mediated
luteinizing hormone and follicle-stimulat-
ing hormone release (51). The PCB-pitu-
itary interactions in thyroid hormone
homeostasis were discussed in the previous
section and T4-estrogen interactions are
well documented (32,38).
Table 3 demonstrates the breadth of
congeners with some suggestion ofweak
estrogenic activity. About 50% ofthese (if
CBs 47 and 48 are included) are environ-
mentally relevant, so additivity is a definite
possibility. Even though many ofthese rel-
evant CBs (CBs 18, 52, 77, 95, and 110)
are not persistent, pulses occur through
various exposure routes (see "Sources and
Identities of Intermittent Congeners").
However, as with thyroid disruption, these
transient exposures may lead to biolog-
ically significant manifestations only in
developing animals.
Table 3 also emphasizes the paucity of
data for ER-related effects ofenvironmen-
tally relevant PCBs and it is hoped that
additional in vivo data will be generated.
The public health significance of PCB
estrogenicity is far from established. At the
same time, little advantage is gained by
ignoring estrogen-like PCB actions until (or
in case) a consensus is eventually reached.
The larger disadvantage is that failure to
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consider estrogenicity as a possible adverse
effect of PCBs may result in further
abridgement of effect and occurrence
reports so that biologically plausible associa-
tions with adverse outcomes will be lost due
to missing information. This also argues for
multiple listings ofcongeners in different
categories so that, for example, ifthe estro-
genic action of CB 47 is concluded to be
inconsequential, it can still be considered a
thyroid hormone disruptor (40), neurotoxi-
cant (Table 2), neutrophil activator
(28,29), and inducer ofCYPs 2B and 3A
activities (see next section).
EnzymeInduction
PCBs influence the levels and activities ofa
wide spectrum ofenzymes, especially CYP
P450s and UDPGTs. Activities of bio-
transformation enzymes are important
both as bioindicators of exposure, and as
modulators oftoxicokinetics and toxicity.
Occupational exposure to PCBs induces
hepatic enzymes in humans (82) and the
distinct residue profiles ofoccupationally
exposed humans, compared to less-exposed
humans, can be accounted for by consider-
ing enzyme induction and the substrate
preferences ofthe induced enzymes (83).
The more highly chlorinated of the
former commercial PCB mixtures are gen-
erally the stronger inducers. Alvares and
co-workers first reported that Aroclor 1254
induced both PB and 3-MC types ofP450
activity. They later showed that the lower
chlorinated Aroclor 1016, introduced as a
substitute for Aroclor 1242, was mainly a
PB-type inducer in rats (82).
Extensive work by Safe and co-workers
(4,7,84) has firmly demonstrated that 3-
MC-type induction is predictive ofAhR
potency. They also confirmed that mixed
(PB + 3-MC) enzymes can be induced by
some individual congeners as well as mix-
tures. The general rules developed by this
group are used extensively in PCB classifica-
tion schemes and are reasonably universally
understood (1,2,4,5,7,11,22,38,83-85).
Table 4 includes relative CYP induc-
tion potencies, neurochemical potencies,
and ER-related potencies for some of the
more relevant CBs. Although there are no
obvious relationships between induction
and neurotoxicity/estrogenicity, all of the
strong 3-MC inducers have some TCDD-
like toxicities. The coplanar CBs 77, 126,
and 169 have the greatest affinity for the
AhR and are the most potent pure 3-MC
inducers. Mono-ortho CBs with lateral
chlorines (CBs 105, 114, 118, 123, 156,
157, 167, 189) induce both PB and 3-MC
types of activities and have significant, but
reduced, AhR affinities. Some di-ortho CBs
(e.g., CBs 128, 138, 170) with lateral chlo-
rines also induce both types of activities
and have even more reduced affinities for
the AhR. Di-ortho CBs 47, 99, 101, 110,
153, 163, 183, 187, 194, and 199 with 1
or 2 para chlorines are good PB inducers
and have virtually no AhR-mediated toxici-
ties. CBs 110 and 163 are unexpectedly
strong PB-type inducers (42,84); the envi-
ronmentally abundant and similar CB 149
should be assessed. Furthermore, although
of doubtful environmental significance,
other effects of CBs 64, 91, 163, and 164
should be compared to limited data on
CBs 84 (8,9), 95 (27), and 110 (42) to
enhance the understanding of this unique
group ofcongeners.
CYPlAI induction reaches maxima
both in vivo and in vitro and decline at
higher doses. CYPlAI induction also inter-
feres with PB-type induction by complex
mixtures; e.g., ifTCDD-like compounds
are removed from a PCB-landfill extract,
pentoxyresorufin-O-dealkylase (PROD) and
benzyloxyresorufin-O-dearylase (BROD)
induction is enhanced (37). The same phe-
nomenon can be observed with single mixed
inducers: the stronger mono-ortho mixed
inducers (CBs 105, 118, 189) have rather
flat PROD dose-response curves compared
to pure PB-type inducers (84).
It is nowknown that 3-MC-TCDD-like
induction increases aryl hydrocarbon hydro-
lase, CYPIAI, CYP1A2, and CYPIBI;
PB-like induction increases CYP2B1,
CYP2B2, CYP2A1, and CYP3A (2,4,7,13,
17,22,38,82-85). A number ofadditional
phase 1 and phase 2 enzymes, especially
UDPGTs, are also induced in concert
(85,86) or with separate SARs (4,7,31,34,
36-38,87-92). CYPs ofthe 4A family are
induced or suppressed, depending on con-
gener and species (89). This database can be
very useful for developing more complete
associations with the AhR-dependent and
AhR-independent actions of these com-
pounds and for predicting biological activi-
ties of their mixtures. Building on and
expanding this database is recommended.
The selective O-dealkylation and
O-dearylation of resorufin ethers offers a
sensitive in vitro estimation of the selective
induction of critical P450s (7,38,85,
87,93-96). The following activities are dif-
ferentiated by measuring resorufin produc-
tion by oxidation ofthe indicated ethers in a
sensitive fluorometric assay:
* CYPlA1 7-Ethoxyresorufin
* CYP1A2 7-Methoxyresorufin
* CYP2B1/2 PROD and BROD
* CYP3A23 BROD
Positions of testosterone hydroxylation
can also differentiate activities (91,96,97).
For noninvasive estimations, specific
N-demethylations of caffeine can be used
with [13C]caffeine as breath tests for
CYP1A2 and CYP2E1 (96,98). An ery-
thromycin breath test or urinary excretion
of 6,B-hydroxycortisol are useful human
biomarkers for CYP3A4 (91).
Unfortunately, most tests developed as
bioindicators of environmental exposure
have focused on CYPIA activities. PROD
activity has been included in some surveys,
but BROD appears to be a more sensitive
indicator of exposure and may be more
appropriate than PROD. Both basal activity
and PCB inducibility is higher for BROD
than for PROD in prepubertal rodents
(17,37,38,43,71,85,87). Basal BROD activ-
ity is lower in adult female rats than in male
rats and PCB induction ofBROD activity in
adult male Sprague-Dawley rats may be
twice that ofadult females (99). However,
both basal and induced BROD activity in
females is still higher than that ofPROD.
Environmentally, ethoxyresorfin 0-
dealkylase activity is readily induced in fish
whereas PROD activity is not (100). This
may account for the higher proportion of
normally labile congeners, metabolized by
PB-induced enzymes, as compared to copla-
nar congeners which are metabolized by the
coplanar-induced enzymes. CYPlA1 and
CYP1A2 are not induced in aquatic/marine
invertebrates (100), but CYP3A is induced
in blue crabs (101); this may render
fish/shellfish residue profiles distinct.
BROD activity is higher than PROD in
marine mammals (102). BROD may be less
suitable for birds because rat CYP3A1 anti-
bodies do not recognize the protein in
embryonic chicken liver, even though ery-
thromycin N-demethylation is induced by
PB (103). In addition, PROD activity is
induced to a greater extent than BROD by
Aroclor 1260 inJapanese quail (104).
Failure to discriminate between CYP2B
and CYP3A activities with BROD as a sub-
strate is not especially critical as CYP2A1,
CYP2B1/2, and CYP3A are regulated in
concert by an endocrine-sensitive process
(85,86,105). As endocrine disruption is a
major consideration in associating PCB
actions with bioindicators, the more inclu-
sive BROD would be preferred because all
four of these monooxygenases are impor-
tant in the catabolism ofsteroids, especially
testosterone (85,86,91,96,97,105). CYP3A
is also active in the oxidative metabolism of
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chlorinated aromatics (92), even though
CYP1A and CYP2B have been considered
prototypes (7).
In summary, there is a firm link
between enzyme induction and AhR
effects. There are developing associations
between induction and patterns of PCB
body burdens; enzyme patterns and
species/food chain differences in residues;
metabolites and thyroid and ER-mediated
effects. There is a large database describing
enzyme induction by PCBs that has rather
firm SARs for different enzymes. With
induction/effects information on a few
additional environmentally relevant con-
geners and some harmonization of other
SARs, the CYP P450 induction type and
potency seems to be the obvious index for
categorizing associations among the vari-
ous congener types and biological effects.
It is still important to monitor a profile of
biotransformation enzymes when compar-
ing congeners and/or mixtures, when
investigating responses mediated by meta-
bolites, or when using enzyme activities as
bioindicators (38,87,106).
Concepts of PCB Occurrence
With only the considerations in Table 4,
it might seem obvious that the list of
priority congeners (5) should be modified.
Comprehensive reports ofhuman burdens
(83) and dietary exposures (107) confirm
the importance of many congeners not
routinely analyzed (Table 1). Nevertheless,
these congeners recently shown to have
biological activities not mediated through
the AhR have already been omitted from
several analytical studies and reports.
Therefore, it is not unusual for newly
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reported activities to be discounted because
the CBs tested do not appear to be
detected (1) in important matrices. It must
be recognized that not analyzed/not
reported is not synonymous with not
detected; in addition, not detected at a
point in time does not confirm lack of
exposure to labile congeners.
Recent comprehensive characterizations
ofAroclor mixtures, especially those by
Frame and colleagues (12,108), have estab-
lished a set ofoccurrence values that deviate
from earlier studies (14,19,109-112) when
the standards available were severely limited.
Because ofthe better resolution on multiple
systems, availability ofall standards and
close agreement among collaborating labo-
ratories, these values are probably the most
accurate published. It was suggested that the
concentrations of CBs 91 and 95 might
have been reversed in a classic Arodor com-
position study (109) due to a typographical
error. The senior author felt that the error
was due to theoretical retention times
almost too close to differentiate; further-
more, he expressed amazement that more
cross-checking was not practiced before this
16-year-old report (109) was published
intact in more recent documents (P Albro,
personal communication).
Residue determinations conducted for
environmental degradation and distribution
studies still tend to include comprehensive
lists ofcongeners more in line with Aroclor
contents (113-115). Recent relatively
unabridged reports, cross-referenced with
the most recent reports ofAroclor composi-
tions, are the most useful for developing
concepts ofactual exposure profiles. Even in
these studies, important pairs ofunresolved
congeners might be reported as asingle con-
gener or include co-eluting congeners in the
standards that are not present in the sample.
Mass spectrometric differentiation of non-
isomeric co-eluting congeners (e.g., 37/42,
66/95, 77/110) is important, so the
method(s) of analysis should be noted
before examining data tables.
The most universal exposure and global
transport route is atmospheric, and the pro-
file ofcongeners (Table 5) differs markedly
from that normally associated with food
chains and human residues (1,7-9,21,107).
Part ofthis difference is due to the greater
volatility (high in air) and more efficient
metabolism (low in humans) ofthe lower
chlorinated and tri-ortho penta- and
hexaCBs (23,83). Another source ofvaria-
tion is the target analytes of the specific
study. In addition to the mass spectromet-
ric differentiation ofnonisomeric co-eluting
congeners in the Sangamo analyses (116),
there are differences in the airborne con-
geners reported by the two closely related
studies (Table 5) and by a separate labora-
tory analyzing the same extracts (116).
These seemingly minor differences are not
discrepancies. They merely illustrate how
inaccurate concepts ofresidue profiles can
originate and be perpetuated from consider-
ing a limited spectrum ofeven high quality
comprehensive residue reports.
Even within these closely related data
sets, the Green Bay data might be inter-
preted as showing that the very significant
congeners 22 and 41 (Sangamo data set)
were not present (Table 5). Likewise, the
Sangamo data set did not include CBs 24,
26, and 63 reported at significant levels in
the Green Baystudy. This is more likelydue
to the analytes targeted rather than major
distinctions in the two sets ofsamples.
A totally different perception ofairborne
PCBswould be formed from theplant accu-
mulation data (Table 5). Peaks containing
CBs 17, 47/48, 56/60, and 101 were consis-
tently found at 2 to 3% of the airborne
PCBs (Table 5). However, it might be
assumed that the important CB 17 (Table
1) is absent from plants and CBs 47/48 and
56/60 are found only in vascular plants.
Again, the differences are due mainly to
choice ofanalytes, which is sometimes influ-
enced by interferents peculiar to the matrix
being analyzed.
The CB 77/110 peak dominates the
plant samples even though it contributes
only a modest percentage ofthe airborne
PCBs (Table 5), so one or both CBs may
have specific plant accumulation potential.
This might be due to the greater number
of congeners reported for the air samples
(which would decrease the relative contri-
bution ofindividual values). On the other
hand, this peak was also the most consis-
tently dominant one in lettuce, potato, and
tomato samples collected either near the
New Bedford, Massachusetts, superfund
site or from nonlocal markets (119), which
may account for high levels in the Italian
national diet (107). As with the lichens
(117), confirmed airborne CBs 17, 47/48,
and 56/60 were not target analytes in the
New Bedford study (119).
Although these differences in reported
compositions may seem trivial and possi-
bly irrelevant, they serve to emphasize that
exclusion from an analytical report may
simply mean that the congener was not a
targeted analyte. Such exclusions build a
base ofhistoric data that influence future
congeners selected for analysis, further dis-
torting concepts of actual PCB profiles.
The residues are adequately complex so
that abridged reports of major congeners
are preferred by many over more complete
and detailed characterizations, further
entrenching concepts offalse absence.
Human BodyBurdens
Recent comprehensive residue determination
studies in humans are rare because ofthe
selection of high priority congeners for
quantitation. In older studies with limited
standards available (120,121), there may be
poor agreement among the congeners
reported (19). There is, however, general
agreement that CBs 138, 153, and 180 are
the most consistently detected and quantita-
tively dominant congeners in human adi-
pose tissue and breast milk (120-131). CBs
28, 118, and 170 also make frequent large
contributions; the coplanar congeners 77,
126, and, less often, 169, make toxicologi-
cally important contributions. Together,
CBs 138 and 153 frequently account for 40
to 60% of the reported PCB congeners
(Tables 6, 7). Concentrations ofCBs 138,
153, and 180 are highly correlated with
total PCB in breast milk and can be used to
determine important geographical and tem-
poral trends (123,127-131). When cor-
rected for background levels, it was also
determined that these CBs were 96 to 98%
absorbed by an infant from mother's milk
(131). Therefore, they serve as useful, read-
ily obtained values for general concepts of
infant exposure. The result, however, has
been that many attempts to associate disease
with chlorinated aromatics have used highly
abridged data consisting primarily ofthese
three congeners and total dioxin TEQs.
Possible associations with other congeners
can be neither suggested nor denied.
The lack of testing associations among
unreported congeners and diseases is
basically unnoticed because ofmisconcep-
tions regarding occurrence. The same
potential misconceptions resulting from the
choices ofcongeners reported (as discussed
for airborne PCBs in Table 5) can be noted
for breast milk PCBs (Tables 6, 7). For
example, the Inuit (122), Dutch (123), and
Norwegian (126) studies did not report
peak 77/110 but analyzed CB 77 separately;
the other three studies (112,124,125)
reported peak 77/110 collectively. Vari-
ations in the reported contributions from
CBs 74, 101, 128, 138, 153, and 180 might
well be explained by population/geo-
graphical differences or the numbers ofcon-
geners considered in the percentage
contribution calculations. Examples of
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Table 6. PCB congeners reported in human breast milk
samples(mean nanogram per gram milkfat).
Quebeca
Inuit Rural Dutchb
n=35-109 n= 16x6 n= 19
1989-1990 1988-1989 1990-1992
Congener 1st3 daysc 14-21 days 7-14days
28 12.1
52 2.6
66 11.6
70 18.5
77 0.025 0.008 0.019
99 19.7
101 1.5
105 4.4 9.4
118 58.7 17.4 35.5
126 0.209 0.08 0.152
128 4.0
137 16.8
138 230.6 38.9 129.9
141 1.1
151 0.9
153 394.8 37.4 174.7
156 6.2 21
169 0.221 0.033 0.084
170 45.9 10.3 37.1
177 6.3
180 191.2 20.2 76.8
183 12.2
187 20.0
194 8.6
195 2.9
202 0.9
Total 922 135 608
aData from Dewailly et al. (122). bData from
Koopman-Esseboom et al. (123). cPostpartum time of
samples.
congeners consistently found in most
studies, but simply not included as analytes
in other studies, are CBs 141, 157, 183,
187, and 206 (Table 7).
Experimental, occupational, and ambient
exposures are to rather consistent levels of
similar composition mixtures. Ifnearly all
the PCBs ever detected in human tissues
are considered, lifetime accumulation
factors from Aroclor 1260 can be deter-
mined from very ambitious correlations
with other constants (83). Equilibrium
proportions ofcongeners in human tissues
are generally achieved under rather con-
stant exposure conditions within a few
years, but these proportions will differ
between highly exposed persons and those
with normal levels (83). In addition, inter-
mittent changes in lifestyle (e.g., refuse
worker in Bloomington, Indiana, to sport
fishing in Green Bay, Wisconsin) can dis-
tort the equilibrium residue composition.
Total PCB residues may stay constant.
Although there have been suggested rela-
tionships, total serum PCB levels do not
correlate especially well with specific disease
conditions such as breast cancer (132,133).
Better biologically plausible associations
have been found with more specific and
more direct measurements. In actual breast
tissue, CB 99 (weakly estrogenic in Table 5)
and DDE correlated strongly with ER-posi-
tive breast cancer whereas mirex and the
mono-ortho CB 1 18 (coplanar, probable
antiestrogen) correlated strongly with ER-
negative breast cancer (134). In another
recent study, the association between AhR
agonists and non-Hodgkin's lymphoma
(NHL) was reasonably discounted, but a
positive association between adipose levels
ofhigher chlorinated non-coplanar PCBs
and the disease was found (135). Aseparate
study has reported a highly significant cor-
relation between total serum PCB and
NHL (136).
In order to determine ifthese correla-
tions are of public health significance
(132-136) or coincidental (83,137), more
reliable PCB analyses must be conducted
(138) and more complete descriptions of
unabridged residues must be compared.
No biologically plausible associations can
be found for PCBs not investigated
because they are infrequently reported
and/or not reported because they are virtu-
ally uninvestigated. For the more labile
congeners, especially in developing animals
and humans, pulses ofexposure may result
in developmental changes not apparent
until later in life when all evidence of the
exposure (residues) are erased. Thus, it is
important to consider congeners that are
found intermittently (low frequencies) but
at significant levels.
Sources andIdentities
ofInterniittent Congeners
Another criterion for excluding some
congeners from already complex analytical
profiles is inconsistent or low frequency
occurrence. Some means ofdata reduction is
necessary and this can be accomplished by
reporting ranges and/or mean concentrations
and/or median concentrations. For intermit-
tently present congeners, measures ofcentral
tendency are decreased when used for the
entire data set. Occasionally, frequencies of
detection above the limits ofquantitation
are also included but few readers have the
time or inclination to take these into consid-
eration or ponder over the implications. It is
the responsibility of the analyst to ensure
that the data and notations are not repeat-
edly abridged, thereby creating false impres-
sions even ifunintentional (19). Even ifthis
responsibility is met (124-126), it is the
reader's responsibility to make note ofthese
exceptions when forming and relating
concepts ofoccurrence.
Many of the congeners most often
considered absent from food chains are not
targeted in human samples, but are present
at high levels in the environment (Table 5
vs Tables 6 and 7). These include many
lightly chlorinated (diCB and triCB)
congeners such as 4, 8, 16, 17, 18, 31, and
33 as well as the tetraCBs 47, 48, 49, 56,
60, and 70. TriCB 28 and tetraCBs 44,
52, 66, 74, and 77 are more frequently
reported. Many of the infrequently
reported lightly chlorinated congeners are
active (or share characteristics with active
but environmentally irrelevant congeners)
in neurotoxicity (Table 2) or estrogenicity
(Table 3) assays.
Confirmation oftemporary exposure to
lower chlorinated CBs was presented as
early as 1981; currently exposed and occa-
sionally exposed capacitor workers had
higherproportions oflower chlorinated CBs
than did past-exposed workers (139,140).
After a capacitor accident, several CBs
including 18, 28, 33, and 66 were greatly
elevated in the serum and adipose tissue of
exposed workers (141). One month later,
adipose levels ofCB 18 were 10-fold lower,
but still 4- to 10-fold higher than in the
general population. Concentrations ofCBs
153 and 156 remained very similar during
the 30-day period, while CBs 101, 171, and
183 declined along with the lower chlo-
rinated congeners (141). Should such
accidental (or intense airborne) exposures
occur in a nursing mother, the record of
exposure would be erased before potential
developmental deficits were realized.
Surprisingly, serum levels of CB 74
increased 4-fold and adipose levels dou-
bled during this same period (141). It is
possible that the CB 74 was mobilized
from an unsampled adipose compartment
(142), but the other congeners remained
stable or declined. Thus, it adds credibil-
ity to previous suggestions (83,120) that
increases in human body burdens of the
virtually unstudied CB 74 might be due
to dechlorination of higher chlorinated
congeners in humans.
As with many ofthe lower chlorinated
congeners, the 2,3,6-substitution pattern is
very susceptible to metabolism by mam-
mals (7-9) and most ofthese congeners are
not considered important components of
food chains. Hydroxy metabolites may be
relevant, but this 2,3,6-substitution pattern
is also the most susceptible to formation of
methyl sulfonyl products through epoxida-
tion and the intestinal f-lyase pathway
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(143). These metabolites are persistent,
bioactive (143,144), and probably respon-
sible for selective accumulation in lung and
liver (145).
Accumulation of parent CB 110 in
produce has been described previously
(119). The 2,3,6-chlorinated CBs 84, 91,
136, and especially 95, 110, and 149 are
significant components ofAroclors (12,108)
environmental residues (Table 5), and some
tend to concentrate to greater extents than
some ofthe more prevalent congeners in
pelagic fish such as tuna (146). Although
co-eluting CB 66 is generally about 50%
higher than CB 95 in Aroclors (12) and
environmental samples (116), they are pre-
sent in about equal proportions in National
Institute of Standards and Technology
marine reference materials (147). CB 149,
although initially included for quality assur-
ance/quality control confirmation of CB
118 resolution (19), is found at significant
levels in most marine samples (148). CBs
101, 110, and 118/149 dominate profiles in
some Siberian lakes and fishes (149).
Fish have readily inducible CYP lA
activity and moderate to low CYP 2B/3A
activities (100); therefore, coplanar and
mono-ortho congeners would be depleted
relative to lower chlorinated as well as
tetraCBs, pentaCBs, and hexaCBs with 2
and 3 ortho chlorines. This is further sug-
gested by comparing diverse fish residue
studies in order to provide a more complete
profile of congeners detected through the
different profiles of congeners selected for
analysis (Table 8). These profiles have little
resemblance to the profiles reported for
human breast milk (Tables 6,7). Even the
readily metabolized (by mammals) CB 4 was
found in small lake trout and whitefish, but
was below detection levels in medium and
large fish (150). CBs 66/95, 101, and 110
were found in 100% of the samples of 98
fish comprising 15 different species from
various waters inWisconsin (153) (Table 9).
A more recent study (154) that quanti-
tated 91 peaks representing well over 100
CBs in Lake Superior whitefish, trout, and
walleye as well as carp and Pacific salmon
(control) further distinguished fish residue
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Table L Partial compositions ofPCBresidues infishasreportedbyvariousauthors.
Hudson Lake
Estuary Superiorh LakeOntarioc
DeepN.
Atlanticd
C. aratus
B&Zno. Striped bass Largelaketrout Laketrout Cohosialmon (Rattail
18++ 2.4.0
31 1.9
.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
40 1.71
44 2.3 0:8
49. 4.7 3.43- 0.|-
56+6
on n8+ .1..
60 .'. ." 0.33-
66 2.41.4_42.
770.8 Q1
82. 3.8
85 1.2
87 -. .59
.95 ~~~~~~~~~~~~~~~~~~~~~3.71 .1.71A0: 451
DeepN..
Hudson Lake At.lantiCd
Estua Supen~rbo LakeOntardoc C. armatufs
B&Zno. Stripedbass large'taketrout Laketrout Cohosalmon (Rattaii)
99 2.8
105 0,, 254 244 47
lt8 2.5 6.00. 6.36 5.0
129 .2,4G.
137 .4.29 1.68.
141 1.9.7. 168, 0}55
151 -1.3:
156 ..
170+190 2.07 16
182+187 2.86 V:6-
187 1.7 5.14
194. 0.6 1.60. 0.56 -0.46. 2.16.
196+23 1.25 1.02.
203
207 03
% Sum 83.544. 83.U1l.~ .97.875.
,On=~~~~~~~~~~~ 0. Ohraes wees 'ldFai'ltnp .-...:..---.. n=60. Otherareas were sampled. Earlyeluting peaks(CBs4, 10, 18, 19)wereathigh leelsusream but m inal intheestuary(152. Siskiwit Lk*e on Isle Royale.
Alsoinckdesdifferentsizesoftroutandwhitefish. CB4contributedtoresidues insmalltutandwhitefish, wsbls wquan in largerfis (ld. n=10. Onlyth
37 mostcommon of 92 cowngenersmeasured were repoted (6k fn-. From Hudson Canyon off NewYork. Area more contaminated than comparable-collecton Sit off
Nlewfoundand.Primaryobjetive wastoconfir CYPAinduction(151).
profiles from those normally claimed for
the food chain. The only peaks detected
consistently above limits ofquantitation in
all five species were congener pairs 5/8,
16/32, 66/95, 70/76, and 77/110 (154).
Of the 91 peaks, the 6 most dominant
peaks in the carp were CBs 28/31 <49 <
66/95 <41/64/71 < 52 < 16/32.
Human Implications
Serum total PCBs in Native Americans
consuming the well-characterized fish
above (154) were more related to age than
to fish consumption (155). Correlations
with specific congeners have not yet been
tested. Even then, it is unlikely that strong
correlations would be found because most
of these congeners are quite labile in
humans. Nevertheless, pulses ofthese labile
and unexpected congeners would be antici-
pated following every fish meal, although
the intermittent levels would not be as
high and persistent as with the accidentally
exposed workers (141). In fact, such pulses
of total PCB after fish meals have been
recorded with maximum serum levels
being reached in about 10 hr and declining
rapidly to near ambient by 48 hr (156).
The major conclusion, however, must
be that humans and other animals are
intermittently exposed to profiles of PCBs
that leave sparse records of their presence.
Although the persistent congeners 118,
138, 153, and 180 remain dominant in
adult human residues, young fish (153)
and young children (130,157) may retain
congeners infrequently encountered and/or
reported in adults (Table 9).
There are plausible physical-chemical
and toxicokinetic reasons for the distinctly
different profiles of congeners in various
matrices (23). The associations ofPCBs and
Table 9. Congeners found to be prevalent in fish and
children (mean % of total PCB).
High-residue
Congener Fish residues (153) children (157)
or pair Mean % Frequency Female Male
5+8 3.5 0.5
18 1.8 1.8
28+31 7.9 53 2.7 2.7
66 +95 7.4 100
70+76 4.5 72
99 2.9 2.7
101 6.0 100
105 2.6 78
110 6.8 100
118 2.7 92 4.6 6.5
138 8.1 90 17.0 14.0
146 3.4 83
149 4.3 90
153+132 11.0 92 19.6 15.8
170 4.6 3.9
180 3.7 87 8.1 6.8
182+187 2.7 2.0
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other persistent lipophilic substances with
disease conditions mayfrequently be coinci-
dental because ofubiquitous occurrence and
selective retention based on physiological
conditions associated with the disease rather
than vice versa. The associations mayalso be
causal. Some effort is necessary to expand
the database to determine whether PCBs are
guilty ofmany adverse health effects, as sus-
pected. PCBs are broad-acting toxicants and
disrupt neuroendocrine and biotransforma-
tion systems experimentally with a trem-
endous potential for interactions. The
significance ofthese disruptions for public
health and wildlife has not been adequately
defined or even firmly established.
Some, but not all, factors have been
suggested for consideration to develop a
strategy to efficiently and accurately
determine whether medical surveillance
and/or intervention need to be increased or
if resources should be focused on other
problems. The knowledge and experience
gained in defining the high-profile problem
(or nonproblem) ofPCBs will assist in the
evaluation ofother mixtures.
This review is not comprehensive and
some additional complicating factors such
as metabolites and kinetic interactions have
been mostly neglected. For example, per-
haps the persistent metabolites detected in
human serum (76) are "just there," but the
active metabolites have bound to receptors
or other important cellular constituents.
Certainly, little attention has been paid to
the early observation (145) that 2,3,6-chlo-
rinated PCBs and/or metabolites bind
detectably to lung cells but are not found at
significant levels elsewhere in the body.
Insects, which comprise the greatest terres-
trial animal biomass, may play a unique
role in dispersion and biodegradation.
Their unique susceptibilities (158) and
potential for congener profile changes
(159,160) have also not been addressed.
New information regarding the dissociation
ofhepatic effects and other AhR effects in
mice deficient in the protooncogene
C-SRC (161) must also be considered.
If we step backward and look at the
broader picture of PCB toxicity/occur-
rence and recall information previously
reported, we will be in a better position
to accurately assess the risks of environ-
mental PCBs. Table 10 proposes an
expanded list (based on this review) of
PCBs that merit monitoring to encourage
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a broader, more accurate, and more criti-
cal evaluation of the immense body of
PCB information available. It is hoped
that criticisms, comments, addenda, and
most importantly, interest will be stim-
ulated so that plausible toxicological
associations can be confirmed or denied.
Then we can move on to other problems
with knowledge and confidence.
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